What’s Behind The Recent Surge In TherapeuticsMD Inc (TXMD)
Billionaires Portfolio: Biotech stock Therapeutics MD (NYSEMKT:TXMD) was up 32.5% recently.
Friedman Billings Ramsey raised their price target for the stock to an incredible $34. TXMD now trades at $5.47 — the FBR price target would mean a 600% return.
TXMD is owned by the billion dollar biotech hedge fund RA Capital Management. RA is the best in the business of biotech investing, and owns more than 6% of TXMD.
RA is one of our favorite hedge funds to piggyback. Its a billion dollar biotech focused hedge fund run by Peter Kolchinsky, a PHD from Harvard. The fund has one of the best track records in the world, averaging 41% a year since 2002.
Please don’t miss the opportunity to learn more about me and how we follow Billionaire Investors into stocks by visiting the Billionaires Portfolio.
The insider behind the Billionaire’s Portfolio is William Meade. William started his career with Wood Asset Management. Wood Asset Management was a $1.5 billion dollar institutional asset management firm and hedge fund, founded by Gary Wood, a former Goldman Sachs Partner and Harvard MBA. At Wood, William helped manage equity and fixed income portfolios for major university endowments, Fortune 500 pension funds and super high net worth clients (including 2 billionaire families).
Next, William was Director of ETF and Mutual Fund Research for Zacks Investment Research in Chicago. At Zacks, he worked with the founder Len Zacks, a PHD from MIT, in developing and maintaining a proprietary model that ranked over 20,000 ETFs and mutual funds. This model was viewed and used by over 150,000 people monthly, and was published in US News and World Report, and featured on CNN, Yahoo Finance, and Fortune.com.
William received a Masters in Economics from Johns Hopkins University, including PhD level coursework in International Economics. At Johns Hopkins, Mr. Meade was taught by Economists from The Federal Reserve and Department of Treasury. While at Johns Hopkins Mr.Meade consulted for a top hedge fund in Washington DC.